ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,701.70
0.96%
S&P ASX All Technology
3,075.00
0.84%
Brent Oil
81.295
0.00%
US Dollar vs AUD
1.49858
0.00%
Bitcoin
67,713.83
-0.02%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Myriad Genetics Inc (MYGN)

  7. Myriad Genetics Inc (MYGN) News

MYGN

Myriad Genetics (MYGN)

Myriad Genetics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MYGN
DateTimeSourceHeadlineSymbolCompany
31/05/202407:55GlobeNewswire Inc.QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applicationsNASDAQ:MYGNMyriad Genetics Inc
24/05/202408:00GlobeNewswire Inc.Myriad Genetics Showcases New Research and Product Innovations Advancing Cancer Care at 2024 ASCO® Annual MeetingNASDAQ:MYGNMyriad Genetics Inc
17/05/202406:05GlobeNewswire Inc.New Study Published in JCO Precision Oncology Shows Myriad Genetics' Prolaris Test Can Predict Benefit of Hormone Therapy Treatment in Men with Localized Prostate CancerNASDAQ:MYGNMyriad Genetics Inc
16/05/202407:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
16/05/202407:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
16/05/202406:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MYGNMyriad Genetics Inc
15/05/202406:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MYGNMyriad Genetics Inc
14/05/202406:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MYGNMyriad Genetics Inc
14/05/202402:14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MYGNMyriad Genetics Inc
08/05/202422:23IH Market NewsReddit Rises 15% After First Quarterly Report, Upstart and Twilio Plunge Due to Weak Q2 Forecast, and More in EarningsNASDAQ:MYGNMyriad Genetics Inc
08/05/202422:14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MYGNMyriad Genetics Inc
08/05/202406:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MYGNMyriad Genetics Inc
08/05/202406:05GlobeNewswire Inc.Myriad Genetics Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue Growth Year-Over-Year; Significantly Improved Year-Over-Year Net Loss and Generated Positive Adjusted EBITDANASDAQ:MYGNMyriad Genetics Inc
07/05/202423:00GlobeNewswire Inc.Myriad Genetics Announces Reorganization of European Operations and Sale of EndoPredict BusinessNASDAQ:MYGNMyriad Genetics Inc
01/05/202406:05GlobeNewswire Inc.Myriad Genetics to Release First Quarter 2024 Financial Results on May 7, 2024NASDAQ:MYGNMyriad Genetics Inc
17/04/202422:00GlobeNewswire Inc.Nearly Half of Americans Say They’ve Lost Time in Their Lives Due to Poor Mental Health, According to the GeneSight Mental Health MonitorNASDAQ:MYGNMyriad Genetics Inc
16/04/202423:15GlobeNewswire Inc.New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal ScreenNASDAQ:MYGNMyriad Genetics Inc
09/04/202422:00GlobeNewswire Inc.Myriad Genetics Research Shows Reduction in Hospitalizations for Patients with Depression after GeneSight TestingNASDAQ:MYGNMyriad Genetics Inc
22/03/202412:40GlobeNewswire Inc.Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority DateNASDAQ:MYGNMyriad Genetics Inc
21/03/202407:05GlobeNewswire Inc.Myriad Genetics Announces Patent Granted for SneakPeek® Snap DeviceNASDAQ:MYGNMyriad Genetics Inc
05/03/202408:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
29/02/202400:31Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:MYGNMyriad Genetics Inc
28/02/202408:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MYGNMyriad Genetics Inc
28/02/202408:05GlobeNewswire Inc.Myriad Genetics Reports Strong Fourth Quarter and Full-Year 2023 Financial Results; Fourth Quarter Revenue of $197 Million and Full-Year Revenue of $753 Million Each Grew 11% Year-Over-Year; Delivered GAAP EPS of $(0.36) and Adjusted EPS of $0.04 in the FoNASDAQ:MYGNMyriad Genetics Inc
28/02/202401:15GlobeNewswire Inc.Myriad Genetics and National Cancer Center Hospital East in Japan Collaborate on Pan-Cancer MRD Monitoring Clinical Trial, SCRUM-MONSTAR-SCREEN-3NASDAQ:MYGNMyriad Genetics Inc
27/02/202408:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
27/02/202408:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
22/02/202408:05GlobeNewswire Inc.Myriad Genetics to Release Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024NASDAQ:MYGNMyriad Genetics Inc
16/02/202408:05GlobeNewswire Inc.Myriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as Principal Medical Advisor of Women’s HealthNASDAQ:MYGNMyriad Genetics Inc
15/02/202408:47Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MYGNMyriad Genetics Inc
 Showing the most relevant articles for your search:NASDAQ:MYGN

Your Recent History

ASX
NCM
Newcrest Mining
NASDAQ
AAPL
Apple
ASX
XMM
S&P ASX 300 Metals and M...
NASDAQ
QQQ
Invesco QQQ Trust Series 1
FX
EURAUD
Euro vs AUD
NASDAQ
TSLA
Tesla
NYSE
VZ
Verizon Communications
COIN
BTCUSD
Bitcoin
FX
AUDJPY
AUD vs Yen
ASX
WDC
Westfield
ASX
WES
Wesfarmers
NYSE
XOM
Exxon Mobil
NYSE
MRK
Merck
ASX
XTO
S&P ASX 100
FX
AUDUSD
AUD vs US Dollar
FX
GBPAUD
Sterling vs AUD
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved